Concepedia

Jessie Gu

JG

Statistics

Publications

11

Citations

893

H-Index

10

Active since

2008

Affiliations

Sarah Cannon(Current)

Dana-Farber Cancer Institute

Fred Hutch Cancer Center

National Cancer Center Hospital East

Tokyo National Hospital

Jessie Gu is an author at Sarah Cannon specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2008–2023

11

Publications

11

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 494 citations

, , +11

Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults

Konstantin Dobrenkov, Irina Ostrovnaya, Jessie Gu et al. · Pediatric Blood & Cancer · 2016 · 140 citations · Full text

TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC).

Yasushi Goto, Wu‐Chou Su, Benjamin Levy et al. · Journal of Clinical Oncology · 2023 · 50 citations

, , +21

A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Susan O’Brien, Nicole Lamanna, Thomas J. Kipps et al. · Journal of Clinical Oncology · 2013 · 49 citations

, , +19

The Potential of Genes and Other Markers to Inform about Risk

Margaret S. Pepe, Jessie Gu, Daryl E. Morris · Cancer Epidemiology Biomarkers & Prevention · 2010 · 43 citations · Full text

1–5 of 11